Crossmark Global Holdings’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.89M	Sell	51,090 -18,380	-26%	-$1.07M	0.04%	352
2025 Q4	$4.13M	Sell	69,470 -4,688	-6%	-$255K	0.06%	285
2025 Q3	$4.02M	Buy	74,158 +21,000	+40%	+$1.2M	0.06%	284
2025 Q2	$2.92M	Buy	53,158 +40,229	+311%	+$2.37M	0.05%	335
2025 Q1	$914K	Buy	12,929 +23	+0.2%	+$1.55K	0.02%	639
2024 Q4	$848K	Sell	12,906 -416	-3%	-$27.9K	0.02%	627
2024 Q3	$937K	Buy	13,322 +2,277	+21%	+$190K	0.02%	631
2024 Q2	$909K	Buy	+11,045	New	+$920K	0.02%	614
2023 Q2	–	Sell	-2,128	Closed	-$207K	–	1302
2023 Q1	$207K	Buy	2,128 +105	+5%	+$10.9K	﹤0.01%	1214
2022 Q4	$209K	Buy	+2,023	New	+$190K	0.01%	1183
2018 Q4	–	Sell	-5,218	Closed	-$506K	–	1408
2018 Q3	$506K	Sell	5,218 -80	-2%	-$7.99K	0.01%	940
2018 Q2	$499K	Sell	5,298 -550	-9%	-$48.2K	0.01%	948
2018 Q1	$474K	Sell	5,848 -1,848	-24%	-$159K	0.01%	948
2017 Q4	$686K	Buy	7,696 +228	+3%	+$19.8K	0.02%	798
2017 Q3	$695K	Buy	+7,468	New	+$660K	0.02%	768
2016 Q3	$695K	Buy	+7,468	New	+$703K	0.02%	768